It is essential to share samples between the level 4 labs, as these are what enable the science to be done. By having the specimens on hand, we are able to do diagnostic development, applied research and medical countermeasure development, but a lot of that work is essentially rooted in having access to the samples to do the work.
On April 19th, 2024. See this statement in context.